Articles by Jonathan Stroud
Jonathan Stroud is a 3L in the Washington College of Law evening section, class of 2013. He graduated from Tulane University in 2004 with a B.S. in Biomedical Engineering and from the University of Southern California Annenberg School of Communication in 2006 with M.A. in Journalism. He works full time, is a blogger for the IP Brief, the Senior Symposium Editor for the Administrative Law Review, a Problem Writer for the Moot Court team, a Dean's Fellow for Professor Popper, and a Gillett-Mussey Fellow. He is interested in the ongoing implementation of the America Invents Act, patent litigation, ITC litigation, biotechnology, medical device regulation, FDA law, women's rights, and tort law. The views as posted here are his own, and are written in his capacity as a law student.
Yesterday, the Court of Appeals for the Federal Circuit upheld a jury verdict invalidating Leader Technologies, Inc.’s patent on an online networking system. A reversal may have put Facebook in jeopardy.
Last month, the Supreme Court unanimously threw a wrench into the gears of straightforward § 101 patentability analysis by concluding in Mayo Collaborative Services v. Prometheus Laboratories, Inc. that an abstract idea—like the pharmacokinetic relationship …
Pay-for-delay lives on. According to the Blog of Legal Times, ethically questionable settlement agreements between generic and brand-name pharmaceutical companies, or “pay-for-delay” settlements, are alive and well. What is fascinating is that these deals would …
“Few have questioned the wisdom of [§ 101 subject matter challenges], despite the metaphysical gauntlets it has visited upon the learned members of the courts, and the sometimes eccentric results of its application.”
The Supreme Court …
Importers from China beware: if the company you are importing from violated U.S. trade secret laws, the U.S. could turn your goods away at the border, regardless of whether the product itself violates any laws. …
In an appeal from a complex lower-court decision finding Amazon.com was infringing with its online checkout system, the Federal Circuit ruled that Amazon infringed but that the challenging patent was invalid, in a ruling that …
In a case that could have huge financial repercussions for Internet services like Spotify, Hulu, Pandora, Kindle, and other Internet content providers, the Federal Circuit upheld a patent to a business method of providing copyrighted …
In Classen Immunotherapies, Inc. v. Biogen Idec,[1] released August 31, 2011, the Federal Circuit sent the clearest message to the patent bar yet: Stop wasting our time with § 101 subject-matter challenges.
The case, which was on …
The Federal Circuit’s 2-1 Myriad decision upholding the patentability of isolated human genes represents sound judgment and takes into account the well-settled expectations of the parties affected by the ruling.
Let the infighting begin.
In a letter to the Federal Circuit last Thursday, the Acting Solicitor General (ASG) personally requested that he be allowed to present a third set of oral arguments on the government’s behalf …
